Investor Alert

Dow Jones Newswires Archives | Email alerts

Aug. 10, 2022, 5:34 p.m. EDT

Polyrizon Files for IPO

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

By Stephen Nakrosis

Biotech company Polyrizon Ltd. filed for an initial public offering with the U.S. Securities and Exchange Commission on Wednesday.

The company said it plans to offer units in its IPO, which will consist of one ordinary share and two warrants, each for the purpose of buying one ordinary share. The company didn't give an expected size for its IPO, nor did it provide an anticipated price range.

The company said it is developing medical device hydrogels delivered in the form of nasal sprays that can provide a barrier against viruses and allergens.

Polyrizon, which has headquarters in Israel, said it applied to list its shares and warrants on the Nasdaq Capital Market.

Aegis Capital Corp. is listed as the offering's sole book-running manager.

Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

This Story has 0 Comments
Be the first to comment
More News In
Dow Jones Newswires

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.